Share repurchase programme
Werte in diesem Artikel
Nørresundby, 5 February 2024
Announcement no.11/2024
The Board of Directors of RTX has, cf. company announcement no. 20/2023 dated 30 November 2023, resolved to initiate a share buy-back programme in accordance with the provisions of Article 5 Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 (MAR) and the Commission’s delegated Regulation (EU) 2016/1052, also referred to as the "Safe Harbor" regulation.
Under the programme RTX will buy back shares for an amount up to DKK 20 million in the period from 1 December 2023 to 30 September 2024.
The following transactions have been made under the programme in the period below:
| Number of Shares | Average Purchase Price | Transaction value in DKK | |
| RTX shares prior to initiation of the programme | 258,528 | ||
| Accumulated share in the programme, latest announcement | 71,836 | 5,188,479 | |
| 29 January 2024 | 2,500 | 77.52 | 193,800 |
| 30 January 2024 | 2,500 | 84.60 | 211,500 |
| 31 January 2024 | 2,000 | 85.14 | 170,280 |
| 1 February 2024 | 2,000 | 88.82 | 177.640 |
| 2 February 2024 | 1,800 | 91.04 | 163,872 |
| Accumulated under the programme | 82.636 | 73,89 | 6.105.571 |
| RTX total shares | 8,467,838 | ||
| RTX Treasuty shares | 341,164 | 4.0% | of share capital |
In accordance with the Regulation (EU) No. 596/2014, transactions related to the share buy-back programme are presented in detailed form in the appendix attached to this company announcement.
Enquiries and further information:
CEO Peter Røpke, tel +45 96 32 23 00
Attachment
Ausgewählte Hebelprodukte auf RTX A-S
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf RTX A-S
Der Hebel muss zwischen 2 und 20 liegen
Aktuelle RTX A-S Aktie News
RTX A-S Analysen
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für RTX A-S nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
Keine Analysen gefunden.